Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Clene Inc. - Common Stock (NQ:CLNN)

8.452 -0.068 (-0.80%)
Streaming Delayed Price Updated: 11:16 AM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clene Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Clene Nanomedicine Reports Topline Results of Phase 2 COVID-19 Study of CNM-ZnAg
From Clene Inc.
Via GlobeNewswire
News headline image
Clene Announces Closing of $5 Million Debt Facility from the State of Maryland
Funding Demonstrates Importance of Working with Private Sector to Improve Lives of Marylanders, says Governor Hogan 
From Clene Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
VISIONARY-MS Trial Results Featured in Platform Presentation at PACTRIMS 2022: CNM-Au8® Demonstrated Global Neurological Improvement in Stable MS Patients as Adjunct to Background Disease Modifying Therapies
From Clene Inc.
Via GlobeNewswire
News headline image
Recap: Clene Q2 Earnings ↗
  Clene (NASDAQ:CLNN) reported its Q2 earnings results on Monday, August 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Clene: Q3 Earnings Insights ↗
Clene (NASDAQ:CLNN) reported its Q3 earnings results on Monday, November 7, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Clene beat estimated earnings by... 
Via Benzinga
News headline image
Clene Reports Third Quarter 2022 Financial Results and Recent Operating Highlights
From Clene Inc.
Via GlobeNewswire
News headline image
Clene Announces $10.8 Million Registered Direct Offering and $5 Million Debt Facility from the State of Maryland
From Clene Inc.
Via GlobeNewswire
News headline image
A Look Into Healthcare Sector Value Stocks ↗
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators... 
Via Benzinga
News headline image
Clene Shares Fall Despite Multiple Sclerosis Candidate Showing Neurological Improvements ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  During Monday's session, 96 stocks hit new 52-week lows. 
Via Benzinga
News headline image
New Drugs And Therapies Are Giving MS And ALS Sufferers New Hope ↗
People suffering from incurable neurological diseases such as multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS) hope new therapies and drugs will arrive sooner than later.    
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  Wednesday saw 127 companies set new 52-week lows. 
Via Benzinga
News headline image
Why Vicinity Motor Is Trading Higher By Over 65%; Here Are 26 Stocks Moving Premarket ↗
Gainers Vicinity Motor Corp. (NASDAQ: VEV) rose 65.4% to $1.72 in pre-market trading. Vicinity Motor started deliveries of the first Class 3 electric truck to roll off the assembly line in Canada. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 44 companies hit new 52-week lows. 
Via Benzinga
News headline image
Domino's Pizza To $385? Plus This Analyst Cuts Price Target On Adaptimmune Therapeutics By Around 79% ↗
UBS cut the price target on Domino's Pizza, Inc. (NYSE: DPZ) from $430 to $385. Domino's shares rose 4% to $329.11 on Tuesday. 
Via Benzinga
News headline image
Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday ↗
Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per... 
Via Benzinga
News headline image
Nasdaq Jumps 270 Points; Silver Surges Over 8% ↗
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing around 270 points on Monday. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session ↗
Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share. 
Via Benzinga
News headline image
S&P 500 Surges 2%; Crude Oil Rises Sharply ↗
U.S. stocks extended gains midway through trading, with the Dow Jones gaining more than 600 points on Monday. 
Via Benzinga
News headline image
US Stocks Open Higher; Dow Jumps 250 Points ↗
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 250 points on Monday. 
Via Benzinga
News headline image
Why Clene Shares Are Trading Sharply Lower Monday ↗
Clene Inc. (NASDAQ: CLNN) shares are trading lower by 25.90% to $2.09 during Monday's pre-market session after the company announced topline results in the Healey ALS Platform trial of CNM-Au8. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Gainers LogicBio Therapeutics (NASDAQ:LOGC) shares moved upwards by 641.3% to $2.02 during Monday's pre-market session. The company's market cap stands at $66.5 million. 
Via Benzinga
News headline image
Clene Stock Falls As Lead Asset Fails To Show Survival, Function Benefit In Amyotrophic Lateral Sclerosis Trial ↗
 
Via Benzinga
News headline image
Clene Reports Topline Results Demonstrating Survival Signal for CNM-Au8® in Healey ALS Platform Trial
From Clene Inc.
Via GlobeNewswire
News headline image
Clene to Report HEALEY ALS Platform Trial Topline Results on Monday, October 3
Conference Call and Webcast Set for 8:30 a.m. EDT 
From Clene Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Scopus BioPharma (NASDAQ:SCPS) stock moved upwards by 10.9% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.3 million. 
Via Benzinga
News headline image
Recap Of Monday's Biotech Catalysts - End Of the Day Summary ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
  
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.